INTRODUCTION
Long-term maintenance of the skin epithelium is regulated by epidermal stem cells localized to the basal layer and skin appendages. A tightly regulated balance between proliferation and differentiation of these stem cells must occur to ensure efficient skin renewal, but the mechanisms behind the decision of a keratinocyte stem cell to proliferate or differentiate into a mature keratinocyte are unknown in humans. Characterizing these processes will be crucial to combat skin disorders, such as atopic dermatitis, eczema, psoriasis, skin carcinomas, and premature skin aging, where the balance between proliferation and differentiation is perturbed or lost.
Efforts to delineate the mechanisms that underlie human primary keratinocyte (HPK) stem cell fate have predominantly focused on transcription factors. However, as the shift from HPK proliferation to differentiation implicates cell cycle exit, master cell cycle regulators (such as ubiquitin ligases) known to regulate protein degradation rather than mRNA transcription are inevitably involved. The anaphasepromoting complex/cyclosome (APC/C), first identified to regulate mitosis (King et al., 1995; Sudakin et al., 1995) , is an ubiquitin ligase that controls cell cycle progression through the degradation of key substrates (e.g., cyclins and securin). When bound to its coactivator Cdc20, APC/C Cdc20 activates the metaphase to anaphase transition; when bound to its second coactivator Cdh1, APC/C Cdh1 prevents the G1/S transition (Peters, 2006; Sivakumar and Gorbsky, 2015) .
Here, we show that Cdc20 mRNA levels are up to 10-fold lower in differentiated HPKs (arising from paraclones) compared with HPK stem cells (holoclones), which was confirmed at the protein level. Cdc20 is expressed exclusively in basal and epibasal layers of the skin epidermis, whereas Cdh1 is expressed in all layers with a preference for differentiated layers. Partial silencing of Cdc20 inhibits clonogenicity and promotes differentiation, whereas Cdh1 partial silencing promotes proliferation associated with loss of differentiation markers. These data highlight an unexpected dual role for the APC/C activators in regulating HPK stemness and differentiation in human skin.
RESULTS

Nocodazole treatment induces HPK differentiation but differentiated HPKs have 2N DNA content
Permanent blockade of mitosis using nocodazole correlates with HPK terminal differentiation and polyploidization (Gandarillas et al., 2000) . Therefore, mitotic arrest followed by slippage and endoreplication has been suggested to be the Figure 1 . Cdc20 is exclusively expressed in basal and epibasal layers of the skin epidermis, whereas Cdh1 is amplified in differentiated layers. (a) Staining of the epidermis from skin biopsies (foreskin, 6-year-old male donor) using the indicated antibodies. These results were reproduced using skin biopsies from four different patients (data not shown). Scale bar ¼ 50 mm. (b) Quantification of Cdc20-and Cdh1-positive cells (Cdc20þ and Cdh1þ, respectively) in the LS Quek et al. APC/C and Epidermal Stem Cell Differentiation first step toward HPK differentiation, and differentiated keratinocytes from the human epidermis have been proposed to be mainly 4N and polyploid (Gandarillas et al., 2000; Zanet et al., 2010) . This contrasts with murine data where freshly isolated epidermal cells from skin (mainly differentiated) exhibit a single G0/G1 (2N) peak and lack a G2/M (4N) peak and polyploid cells (Foijer et al., 2013) . Using the Rheinwald and Green (1975) cell culture model, we found that nongrowing differentiated colonies (derived from paraclonelike cells) predominantly contain cells in G0/G1 and few cells in S or G2/M compared with growing, progenitorlike (meroclones) and stem-like (holoclones) cells ( Supplementary Figures S1a,b , S2, and S3 online). The classification of each colony was decided based on the criteria described in Barrandon and Green (1987) . Our cell cycle profiling of epidermal cells freshly isolated from human skin biopsies (abdomen and foreskin) reproduced the murine results (w95% keratinocytes were found in G0/G1 and no polyploid cells were detected; Supplementary Figure S1c ). These data differ from Gandarillas et al.'s possibly because of the adverse effects of prolonged nocodazole treatment, such as induction of apoptosis (that may be counteracted by differentiation in the case of HPKs) or mitotic slippage followed by polyploidization. By transiently treating the cells with nocodazole for only 16 hours followed by a 4-day release, we also observed induction of differentiation (Supplementary Figure S4 Figure S4c) , and increased keratin 1 (K1), K10, and K13 expression (Supplementary Figure S4d ). Nevertheless, live-cell imaging initiated immediately after release from nocodazole treatment and run for 72 hours showed that differentiation (characterized here by an increase in cell size) always occurred after normal exit from mitosis (no mitotic slippage was observed). Differentiation started either directly after exit from the initial mitosis, or one to three divisions later (on average, two divisions later), while the average time between divisions increased. By contrast, most of the control cells accomplished at least four divisions within the 72-hour time lapse and were not differentiated at the end of the experiment (Supplementary Movies S1 and S2 online, Supplementary Figure S4e ).
Nocodazole induces a metaphasic block by transiently activating the spindle assembly checkpoint where BubR1 and Mad2 inhibit the APC/C Cdc20 . Therefore, although we cannot exclude other pathways, we hypothesized that nocodazole would promote stabilization of unknown APC/C Cdc20 substrates involved in the positive control of differentiation.
Cdc20 is exclusively expressed in basal and epibasal layers of the skin epidermis, whereas Cdh1 is amplified in differentiated layers Immunohistologic staining of human foreskin epidermis biopsies showed that Cdc20 localized exclusively to occasional cells from the basal and first suprabasal (epibasal) layers ( Figure 1) , an area where the basal marker K14 and the proliferation marker Ki67 were also found, but from which K10 was absent as expected (Supplementary Figure S5 online). By contrast, Cdh1 was expressed throughout the epithelium, with a preference for the epibasal and upper layers ( Figure 1 ). Regarding Cdc20, approximately 7% basal cells and approximately 10% epibasal cells expressed Cdc20, respectively. Amongst these, approximately 73% were Ki67 positive in the basal layer, whereas 100% were Ki67 positive in the epibasal area (indifferently slightly or strongly stained for Ki67). These data indicate that most Cdc20-positive cells are proliferative in vivo. However, 27% Cdc20-positive cells from the basal layer (1.9% of the entire basal population) did not express Ki67. We hypothesized that these Cdc20-positive/Ki67-negative cells could correspond to slow cycling or quiescent stem cells, whereas the Cdc20positive/Ki67-positive and the Cdc20-negative/Ki67-positive cells could be G2/M and G1/S cells, respectively (Cdc20 protein levels are low during S, increase in G2 and M, and gradually decrease during G1). As Cdh1 is preferentially expressed in cells from the suprabasal and upper layers ( Figure 1 ), it is probably amplified in cells undergoing differentiation. However, it is definitely not exclusively expressed in differentiated cells. Indeed, Cdh1 was found in approximately 60% basal cells (presumably undifferentiated as they were K10 negative), and in approximately 70% epibasal cells (amongst these, 54% were Ki67 positive). By contrast, because Ki67 was mainly localized at the epibasal area, only 14% Cdh1-positive cells from the basal layer expressed Ki67 (Figure 1b ). Interestingly, for both the basal and epibasal areas, double-positive cells typically expressed moderate levels of both Ki67 and Cdh1, whereas cells strongly positive for Ki67 were weak for Cdh1 and vice versa ( Figure 1a ). In summary, Cdh1 is expressed in differentiated and undifferentiated HPKs. In the latter, its expression seems inversely correlated with Ki67.
Isolated paraclones express low Cdc20 and high Cdh1 compared with holoclones
We next isolated stem cells (holoclones), meroclones, and paraclones by single cell cloning (Barrandon and Green, 1987) . A total of 672 single cells from the same patient pool of heterogeneous HPKs (foreskin) were isolated after four independent clone isolation series. Protein extraction was performed on two holoclones (H1 and H2) and two meroclones (M1 and M2). For clones presenting an intermediate phenotype between meroclones and paraclones (M/P1-3), and for paraclones (P1-6), the progeny of three and six clones, respectively, were pooled (Figure 2a , left panel) before extraction to obtain sufficient protein material for western blotting. As the involucrin protein level gradually increased from holoclones to paraclones, Cdc20 levels gradually decreased (Figure 2a , right panel), confirming that Cdc20 is highly expressed in epidermal stem cells and lost upon differentiation. The level of the nonmodified Cdh1 different layers as indicated. A total of approximately 2,500 cells (from at least four different fields) were counted for each staining. Statistical analyses were performed by applying a two-way analysis of variance. Data represent the means AE standard error of the mean. The proportions of Ki67-negative (Ki67À, gray bars) and of Ki67-positive (Ki67þ, striped bars) cells within the Cdc20þ and Cdh1þ populations are shown. Epi, epibasal; H&E, hematoxylin & eosin; ns, not significant.
protein (migrating at 55 kDa) did not markedly vary from holoclones to paraclones, but an additional upper band appeared in meroclone samples, which intensified in paraclones and could correspond to a modified form of Cdh1. A unique band, corresponding to DNp63a, was detected using both DNp63 antibody (Figure 2a Quantitative RT-PCR after extraction of mRNA from holoclones, meroclones, and paraclones. Statistical analyses were performed by applying a two-way analysis of variance (n ¼ 9 for holoclones, n ¼ 11 for meroclones, n ¼ 7 for paraclones for K1, K13, Inv, Cdc20, and Cdh1; n ¼ 4 for holoclones, n ¼ 3 for meroclones, n ¼ 3 for paraclones for DNp63, E2F1, and Hes1). All data are represented as the means AE standard error of the mean (upper panels), except Cdc20 and Cdh1 data that are shown as a scatter dot plot where each dot represents one clone (lower panel). Inv, involucrin; K1, keratin 1; K13, keratin 13; ns, not significant. and pan-p63 antibody in HPKs (Supplementary Figure S6 online). Interestingly, DNp63a gradually decreased with the differentiation status of the clones to reach dramatically low levels in paraclones. The same phenomenon was observed for E2F1-a positive regulator of the G1/S transition, recently shown to be an APC/C Cdh1 substrate in keratinocytes (Singh and Dagnino, 2017) .
mRNA was successfully extracted from the progeny of 9 holoclones, 11 meroclones, and 7 paraclones (shown in Supplementary Figure S7 online) . Quantitative real-time PCR (qRT-PCR) showed a massive increase of differentiation markers from holoclones to paraclones and a concomitant dramatic drop in Cdc20 levels. By contrast, Cdh1 was moderately (but significantly) increased in paraclones compared with holoclones or meroclones from the same patient ( Figure 2b ). DNp63, E2F1, and Hes1 levels were also analyzed: Hes1 (used here to test activation of the Notch pathway) and DNp63 levels were consistent between clone types, but E2F1 was downregulated in paraclones ( Figure 2b ).
Immunofluorescent analyses ( Figure 3 ) indicated that paraclones consisted of differentiated colonies only as expected, with no Cdc20, high Cdh1, and very low Ki67 levels. Holoclones consisted of proliferating colonies that exhibited very high Cdc20 and Ki67 levels, and weak (but not negative) Cdh1 levels. Finally, meroclones consisted of both proliferating and partially differentiated colonies (Figure 3 , colonies 1 and 2, respectively) with high Cdc20/intermediate-to-low Cdh1 and low-to-no Cdc20/intermediate-to-high Cdh1 levels, respectively. These data highlight a correlation between high levels of Cdc20 and HPK stemness, whereas a moderate increase in Cdh1 levels correlates with differentiation.
Cdc20 silencing induces HPK differentiation, whereas Cdh1 silencing promotes stemness and proliferation
To test whether changes in Cdc20 and Cdh1 levels were a cause or consequence of differentiation, we inhibited the APC/C by silencing Cdc20 or Cdh1 with small interfering RNAs. qRT-PCR showed that we achieved approximately 60% Cdc20 and approximately 50% Cdh1 downregulation at the mRNA level ( Figure 4c ), and silencing was confirmed at the protein level by western blotting (Figure 4d ). As only 5% cellular Cdc20 is required to trigger mitotic exit (Baumgarten et al., 2009) , approximately 60% reduced Cdc20 expression did not induce notable G2/M arrest (Figure 4a ). However, clonogenicity tests showed that the siCdc20-treated population exhibited a significant loss of colonies (Figure 4b Supplementary  Figure S8 online). No differences in the cell cycle profiles were observed between control (siCtrl)-and siCdc20-transfected cells. siCdh1, however, did lead to a reduced G0/G1 peak and increased S peak (Figure 4a ), likely due to the higher proliferative capacity of these cells compared with siCtrl-and siCdc20-transfected cells.
The early differentiation markers K1, K10, and K13 mRNAs were all upregulated in siCdc20-treated cells and downregulated in siCdh1-treated cells compared with siCtrltreated cells (Figure 4c ), confirming the opposing effects of Cdc20 and Cdh1 on HPK differentiation. Regarding late differentiation markers, involucrin was significantly repressed in siCdh1-treated cells, whereas filaggrin was upregulated in siCdc20-treated cells (Figure 4c ). Although the mRNA fold changes for differentiation genes only reached an approximately 50% increase or decrease after silencing (probably due to 50e60% silencing efficiencies), the variations were significant and reproducible (similar results were also obtained using a distinct set of small interfering RNAs and a different transfection kit; Supplementary Figure S9 online) .
However, DNp63, E2F1, and Hes1 were not found significantly modulated at the mRNA levels here (Figure 4c ).
Protein analyses indicated an increase in K1, K10, and K13 expression in siCdc20-treated cells (Figure 4d ). E2F1 was unaffected in all conditions, but Skp2 (another well-known APC/ C Cdh1 substrate) was stabilized in siCdh1 cells. Although DNp63a was not modulated at the transcriptional level, it was increased at the protein level in siCdh1 cells, indicating that DNp63a is stabilized post-transcriptionally and may thus be an APC/C Cdh1 substrate in HPKs, as previously shown in immortalized keratinocytes (Hau et al., 2011) .
Microscopy confirmed the differentiation phenotype of siCdc20 cells and proliferative phenotype of siCdh1 cells: siCdc20 cells were enlarged compared with siCtrl and siCdh1 cells ( Supplementary Figure S10 online) . Immunofluorescence confirmed that the proportion of K10-positive and filaggrin-positive cells increased in the siCdc20 population compared with control cells (Figure 5a and b) . The siCdc20 dishes exhibited frequent areas of large, differentiated cells expressing moderate-to-extremely high levels of K13 compared with siCtrl cells (Figure 5c and Supplementary  Figure S11 online), whereas involucrin levels were only slightly increased (Figure 5d ). Interestingly, even the siCdc20 cells that were similar in size to controls often had stronger K13 staining (Supplementary Figure S11 , Cdc20 upper panel). In the siCdh1 population, involucrin expression was almost lost (Figure 5d ), confirming the repression observed by qPCR and suggesting a lack of terminal differentiation. K10, K13, and filaggrin expression levels were close to those of siCtrl cells, thus confirming the protein and mRNA data. Strikingly, all siCdh1-treated cells expressed high levels of Ki67, thus revealing a quasi-systematic K13/Ki67 doublepositive signal (Figure 5c , lower panel, white arrow). Similarly, although the Ki67 signal was reduced in the siCdc20treated population, a number of cells still positive for Ki67 also expressed K13 (Figure 5c , middle panel, white arrows). The existence of cells double-positive for proliferation and differentiation markers-a phenomenon that seldom occurred in siCtrl cells-supports an imbalance between proliferation and differentiation after either Cdc20 or Cdh1 silencing, whereby actively proliferative cells are pushed toward differentiation, and differentiating cells are pushed toward proliferation, respectively.
DISCUSSION
Here, we show that the APC/C activators Cdc20 and Cdh1 control stem cell fate in the human skin epithelium via opposing roles on proliferation and differentiation. Cdc20 is LS Quek et al. Flg, filaggrin; Inv, involucrin; K10, keratin 10; K13, keratin 13. found at an extremely low level in differentiated cells compared with proliferative stem cells of the human skin epidermis. As partial APC/C Cdc20 knockdown induces differentiation, we propose that a drop in Cdc20 levels is a cause rather than a consequence of differentiation. Importantly, the finding that manipulation of HPK fate by Cdc20 is independent of its role as a regulator of mitosis is concordant with previous reports of nonmitotic roles for the APC/C Cdc20 during brain development in rodents (Yang et al., 2009) . We found that the lack of Cdh1 prevents differentiation and induces proliferation of stem cells, implying that the presence of Cdh1 is necessary for differentiation. Because only a modest increase in Cdh1 levels was detected during differentiation, its activity might be enhanced by posttranslational modifications. Another possibility is that the ratio between Cdh1 and Cdc20 is the most important parameter (rather than the absolute amounts of Cdc20 and Cdh1) and that this slight Cdh1 increase coupled to a drop of Cdc20 is sufficient to trigger differentiation of stem cells.
APC/C and Epidermal Stem Cell Differentiation
Although a drop in Cdc20 levels has never been reported to induce differentiation, our results after Cdh1 silencing fit well with the known role of APC/C Cdh1 during neuronal differentiation. Indeed, low APC/C Cdh1 activity in human embryonic stem cells correlates with a fast rate of proliferation and a short G1 phase (Bar-On et al., 2010; Coronado et al., 2013) , whereas APC/C Cdh1 activity increases upon neuronal differentiation (Harmey et al., 2009) . Genetic ablation of Fzr1 (encoding Cdh1) in mice leads to embryonic lethality by E12.5. Heterogeneous mice, however, show increased proliferation of brain progenitors, of which 25% develop epithelial tumors compared with 5% wild-type mice (Garcia-Higuera et al., 2008) . These data not only highlight a role for Cdh1 in promoting differentiation, but also suggest a role in preventing neural stem cell proliferation. This agrees with our findings that Cdh1 silencing increases HPK stem cell proliferation and enhances holoclone-like cells frequency. Although we cannot exclude the possibility that the phenotypes observed here after Cdc20 and Cdh1 silencing are independent of their roles as APC/C activators, only two studies have reported APC/C-independent roles of Cdh1 (Liu et al., 2016; Wan et al., 2011) . APC/C-independent functions have not yet been reported for Cdc20. Moreover, Cdc20 and Cdh1 depletion inevitably affects APC/C activity and therefore eventually stabilizes APC/C substrates. We therefore consider a drop in APC/C activity as the primary cause of the phenotypes observed here rather than an APC/C-independent pathway.
APC/C substrates are numerous and it will be challenging to identify which ones drive/inhibit proliferation/differentiation of keratinocyte stem cells. The Wnt/b-catenin signaling is essential for self-renewal of murine interfollicular epidermal stem cells while also preventing their differentiation (Lim et al., 2013) . Interestingly, Axin2, a well-known target of the Wnt/b-catenin signaling but also a potent inhibitor of this pathway, is an APC/C Cdc20 substrate (Hadjihannas et al., 2012) . Stabilization of Axin2 after Cdc20 silencing in keratinocytes may induce downregulation of the Wnt/b-catenin pathway, limiting proliferation and favoring differentiation of stem cells. Our data provide more clues as to relevant APC/C Cdh1 substrates. E2F1 is an APC/C Cdh1 substrate when overexpressed, and its translocation to the cytoplasm followed by degradation correlates with keratinocyte differentiation (Ivanova and Dagnino, 2007; Singh and Dagnino, 2017) . Here, the E2F1 protein expression was lower in paraclones than holoclones, and appeared regulated at the transcriptional level. Whether or not the E2F1 protein is degraded in meroclones and paraclones was not assessed here. Nevertheless, despite repression of differentiation after Cdh1 knockdown, we did not detect any differences in E2F1 levels. Therefore, stabilization of the E2F1 protein as a consequence of Cdh1 silencing is unlikely to drive the proliferative phenotype observed here. Conversely, Skp2, another well-known APC/C Cdh1 substrate in G1, was stabilized after Cdh1 silencing, thus demonstrating that our knockdown did stabilize some APC/C substrates. DNp63a, the main p63 isoform expressed in keratinocytes (Yang et al., 1998) , was very low in paraclones, high in holoclones, and stabilized after Cdh1 silencing.
Interestingly, DNp63 mRNA levels were unaffected by the differentiation status of the clones or after transfection of siCdh1. We propose that DNp63a is post-translationally stabilized by Cdh1 silencing and is therefore an APC/C Cdh1 substrate in HPKs, as previously shown in immortalized human keratinocytes (Hau et al., 2011) . DNp63a is a key regulator of epidermal homeostasis that, amongst others functions, enhances the proliferative capacity of keratinocyte stem cells (Pellegrini et al., 2001) . It maintains proliferation of primary keratinocytes through different mechanisms, including activation of Skp2 transcription (McDade et al., 2011) , activation of the Wnt/b-catenin pathway (Lim et al., 2013; Patturajan et al., 2002) , and inhibition of the Notch pathway (Nguyen et al., 2006) , although the latter was not found significantly modulated here. Although more work is needed, we hypothesize that the mechanism underlying increased proliferation and decreased differentiation of HPK stem cells after Cdh1 silencing involves DNp63a stabilization. APC/C Cdh1 could thus initiate the differentiation of skin stem cells and/or progenitors through the degradation of
DNp63a.
As degenerative changes in tissue-specific stem cells have been associated with aging, APC/C could play a role in aging through control of the stem cell pool renewal. Strikingly, although the expression of BubR1 (the main inhibitor of APC/ C Cdc20 ) decreases with age and BubR1 knockdown induces premature aging in mice (Baker et al., 2004) , its overexpression extends healthy lifespan (Baker et al., 2013) . The underlying mechanism is unclear, and we hypothesize that a loss of stem cells could occur as a consequence of reduced BubR1 levels. Indeed, APC/C Cdc20 activity is expected to increase, accelerating proliferation that in turn could lead to exhaustion of stem cells. This phenomenon is known to occur after overactivation of the Wnt/b-catenin pathway in hair follicles for instance (Castilho et al., 2009 ). This hyperproliferation hypothesis after BubR1 drop is in line with data from human studies showing that monoallelic and biallelic mutations of BubR1 are associated with mosaic variegated aneuploidy syndrome (Matsuura et al., 2006) , where affected patients exhibit not only progeroid features but also a predisposition to cancer.
In conclusion, substrates of the APC/C ubiquitin ligase go far beyond cell cycle regulators and include proteins regulating stemness and differentiation. The next challenge is to identify the relevant APC/C substrates to help manipulate stem cell fate and design better therapeutics for conditions of impaired epidermal homeostasis, such as atopic dermatitis, psoriasis, or premature aging. As the APC/C is a ubiquitous complex, it probably regulates the fate of other tissue-specific stem cells. Therefore, its substrates are promising therapeutic targets to fight degenerative diseases affecting not only the skin but also other organs.
MATERIALS AND METHODS
Isolation of primary keratinocytes from human skin
HPKs were obtained from healthy human skin samples (foreskin from a 6-year-old male donor and abdomen from a 37-year-old female donor) from de-identified surplus surgical waste with written informed patient consent and ethical clearance through the Institute of Medical Biology (IRB numbers: B-14-257E and 2014-034-D). The hypodermis was removed and specimens were minced and stirred in trypsin 0.25%/EDTA 0.01% (v/v 1:1) for 1.5 hours. Isolated cells were washed in cFAD medium (3:1 DMEM/Ham's F-12) supplemented with 10% fetal calf serum and 1% penicillin/streptomycin (Rheinwald and Green, 1975; Simon and Green, 1985) , seeded on a layer of irradiated 3T3-J2 feeder cells (a generous gift from Yann Barrandon), or used immediately for flow cytometry.
Cell culture, transfection, and clonogenicity tests 3T3-J2 fibroblasts were grown in DMEM supplemented with 10% bovine serum and 1% penicillin/streptomycin. To support HPK growth, 3T3-J2 were lethally irradiated by gamma radiation (60 Gy) and 400,000 or 1,200,000 cells were seeded on 6-or 10-cm dishes, respectively, in DMEM/bovine serum. The next day, the medium was replaced with cFAD/fetal calf serum, and HPKs were seeded. The medium was complemented with epidermal growth factor (10 ng/ml) and replaced every 3e4 days.
Transfections were performed using DharmaFECT1 (GE Dharmacon, CO). Small interfering RNAs (GE Dharmacon Lafayette, CO): glyceraldehyde-3-phosphate dehydrogenase (siCtrl; D-001830-01), Cdh1 (L-015377-00), Cdc20 (L-003225-00). For each small interfering RNA, two transfections (separated by 24 hours) were performed.
Clonogenicity tests were performed by plating either 200 or 400 HPKs on 3T3-J2 feeder cells on 10-cm dishes. The cells were grown for 12 days before rhodamine staining.
Isolation of paraclones, meroclones, and holoclones
Single cell cloning was performed as previously described (Barrandon and Green, 1987) . Briefly, single cells were inoculated in 24-well plates (one cell per well). After 7 days, growing colonies were trypsinized and transferred to 10-and 6-cm dishes (half of the colony in each dish). After 12 days, the 10-cm dishes were stained with rhodamine, whereas cells from the 6-cm dishes were harvested for western blotting or qRT-PCR. Initiating cells were classified as follows: >95% large growing colonies of undifferentiated cells ¼ holoclone; >95% terminally differentiated colonies ¼ paraclone; mixture of growing and differentiated colonies ¼ meroclone (Barrandon and Green, 1987) .
Flow cytometry
Cells were fixed in phosphate buffered saline (PBS)/70% ethanol, washed, treated with RNAse A (10 mg/ml), and stained with propidium iodide (10 mg/ml). Flow cytometry was performed on a BD LSR II flow cytometer (BD Biosciences, CA), data were acquired using BD FACSDiva, and quantitative analyses were performed using FlowJo Version 7.2.4 (FlowJo, LLC, OR).
qRT-PCR
RNA was extracted using RNeasy mini or micro kits (Qiagen, Hilden, Germany) and treated with DNase I. Superscript II (Invitrogen, CA) was used for reverse transcription of total RNA with specific primers ( Supplementary Table S1 online). qRT-PCR was carried out as previously described (Thierry et al., 2004) . Values were normalized to TATA-binding protein (TBP) and/or actin and/or glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Immunofluorescence
Cells were fixed in ice-cold acetone/methanol (1:1) for 7 minutes at À20 C, washed in PBS, blocked with PBS/2% fetal calf serum, incubated with primary antibodies ( Supplementary Table S2 online), washed and incubated with secondary antibodies (Alexa Fluor;
ThermoFisher Scientific, Waltham, MA) and DAPI (1 mg/ml) before mounting (Hydromount; National Diagnostics, Atlanta, GA). Images were acquired on Applied Precision DeltaVision deconvolution or Zeiss AxioImager Z1 upright motorized microscopes, and analyzed using SoftWoRx Version 4.0.0 (Germiston, South Africa) or ZEN 2 Version 2.0 (Zeiss, Oberkochen, Germany) software, respectively.
Protein extraction and western blotting
Protein extraction was performed in a PBS buffer composed of 1% triton, 6.6 M urea, and 4 mM EDTA, with protease and phosphatase inhibitors. The samples were sonicated (8-second sonication followed by 8-second pause, for 3 minutes) and equal amounts of proteins were separated by SDS-PAGE before transfer and western blotting (primary antibodies in Supplementary Table S2 ). Protein bands were visualized using ECL Plus (Amersham Biosciences, Amersham, UK). Quantifications were performed using Fiji, ImageJ 1.46r (NIH, Bethesda, MD).
Immunohistochemistry
Paraffin samples were dewaxed in xylene and rehydrated through descending percentages of ethanol to water (3 minutes per solution). Epitope retrieval was performed using antigen retrieval solution, pH 6 or 8.5, depending on antibodies, and the slides were cooled before three washes in PBS/0.05% Tween20. Samples were blocked in 10% goat serum/PBS for 30 minutes, and incubated with primary antibodies ( Supplementary Table S2 ) for 1 hour. They were washed in water and rinsed in PBS/0.05% Tween20. A secondary antibody (Alexa Fluor; ThermoFisher Scientific, Waltham, MA) was added for 30 minutes. Samples were washed in water and rinsed in PBS/0.05% Tween20 before counterstaining with DAPI. A final washing step was performed before mounting (Hydromount; National Diagnostics).
Statistical analyses
All statistical analyses were performed using GraphPad Prism Version 5.03 with one-way analysis of variance, two-way analysis of variance, or t-test as indicated (*P < 0.05; **P < 0.01; ***P < 0.001; ns ¼ not significant). All data represent the means AE standard error of the mean, except the single cell cloning data (for Cdc20 and Cdh1) where each dot of the scatter plot represents one clone.
